Molecular Control Mechanism Of Embryonic Development Unraveled

National Science Foundation (NSF)-funded researchers at the Johns Hopkins School of Medicine in Baltimore, Maryland, and at California's Stanford University have shed new light on the molecular switches that control the complex process by which a single fertilized egg develops into a mature organism. Their paper is published in the February 19, 1999, issue of the journal Cell.

In humans and other mammals, the process is orchestrated in the developing embryo by a set of proteins called "Hox proteins" that control the timely expression of genes -- and thereby control the production of the "next stage" proteins needed for embryonic development. The action of Hox proteins must, in turn, be coordinated to assure the accurate development of an embryo; that coordination involves another set of proteins that act as molecular choreographers.

"Failure of the molecular systems that control development prevents normal embryonic growth, and alterations in these control systems can lead to a wide variety of cancers," explains Kamal Shukla, program director in NSF's division of cellular and molecular biosciences, which funds the research. "Understanding the molecular mechanisms that control normal embryonic development is the first step in developing strategies to prevent these errors, or to repair them when they have gone wrong." Cynthia Wolberger at Johns Hopkins and Michael Cleary at Stanford have made a major step forward in the understanding of these crucial molecular events, Shukla believes.

This research, which uses x-ray crystallography, has led to the determination of the atomic structure of "HoxB1" and a protein called Pbx1, all bound to a fragment of DNA. Pbx1 plays a central role in the modulation of Hox protein function, and mutations in it have been implicated in some childhood leukemias. By visualizing how Pbx1 interacts with a Hox protein and with DNA, Wolberger and colleagues have determined the precise way in which the proteins interact

Contact: Cheryl Dybas
National Science Foundation

Page: 1 2

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Molecular staples shape a cancer killer
5. Molecular motor myosin VI moves hand over hand, researchers say
6. Molecular therapeutics advance fight against brain cancer
7. Molecular motor shuttles key protein in response to light
8. Molecular traffic cop directs cellular signals
9. Molecular marker predicts success of breast cancer treatment
10. Molecular image of genotoxin reveals how bacteria damage human DNA
11. Molecular mechanism found that may improve ability of stem cells to fight disease

Post Your Comments:

(Date:4/9/2019)... ... April 09, 2019 , ... The McLeod Center for ... following a rigorous and voluntary audit conducted by an independent, third-party panel of ... Novalis Certified Centers in the United States, McLeod is the only such cancer center ...
(Date:4/4/2019)... GALWAY, Ireland (PRWEB) , ... April 02, 2019 ... ... discovery, development and commercialization of first-in-class stromal cell immunotherapies, announced it will move ... to become the anchor tenant at the University’s newly created biotechnology park in ...
(Date:4/4/2019)... , ... April 03, 2019 , ... ... stem cell therapies performed at its nationwide Centers of Excellence. R3 wants patients ... cell therapy provider. , To protect patients from Centers that use inferior regenerative ...
Breaking Biology News(10 mins):
(Date:4/10/2019)... ... April 10, 2019 , ... ... locked into multiple agreements to help companies advance their innovations to clinical ... ranging from synthetic biology companies that are gene editing therapeutic cells for ...
(Date:4/9/2019)... ... 09, 2019 , ... USDM Life Sciences , the ... organizations to accelerate innovation and maximize productivity, announces that nearly 100 companies have ... , USDM’s Cloud Assurance is a managed subscription service delivering end-to-end ...
(Date:4/9/2019)... ... April 09, 2019 , ... The American Society of Gene & ... leadership team, including a new addition to the presidential line of succession, at the ... join the Society's leadership team for a three-year term (2019-2021). , All five incoming ...
(Date:4/8/2019)... SAN FRANCISCO (PRWEB) , ... April 08, 2019 , ... ... to accredited investors a $15 million preferred equity investment in the privately held pharmaceutical ... dysfunction. Its leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and ...
Breaking Biology Technology:
Cached News: